| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Dec 18, 2025 | REPLIGEN CORP | Director | Sell | 43.8 | -275 | -0.30% | ✗ | $44.3K |
| Feb 27, 2024 | Feb 28, 2024 | REPLIGEN CORP | Director | Sell | 22.5 | -1,000 | -1.13% | ✗ | $193.4K |
| Aug 29, 2023 | Aug 30, 2023 | REPLIGEN CORP | Director | Sell | 22.5 | -850 | -1.00% | ✗ | $145.7K |
| Sep 9, 2022 | Sep 9, 2022 | REPLIGEN CORP | Director | Sell | 22.5 | -775 | -1.00% | ✗ | $176.1K |
| May 25, 2022 | May 26, 2022 | REPLIGEN CORP | Director | Sell | 17.5 | -14,715 | -16.13% | ✗ | $2.2M |
| Nov 10, 2021 | Nov 12, 2021 | REPLIGEN CORP | Director | Sell | 17.5 | -4,783 | -4.98% | ✗ | $1.3M |
| Nov 2, 2021 | Nov 4, 2021 | REPLIGEN CORP | Director | Sell | 20.0 | -2,400 | -2.56% | ✗ | $729.5K |
| Sep 14, 2021 | Sep 15, 2021 | REPLIGEN CORP | Director | Sell | 40.0 | -274 | -0.29% | ✗ | $80.6K |
| Sep 1, 2021 | Sep 2, 2021 | REPLIGEN CORP | Director | Sell | 20.0 | -3,459 | -3.55% | ✗ | $982.1K |
| Aug 17, 2021 | Aug 19, 2021 | REPLIGEN CORP | Director | Sell | 17.5 | -18,876 | -1.70% | ✗ | $4.8M |
| Jul 20, 2021 | Jul 22, 2021 | REPLIGEN CORP | Director | Sell | 20.0 | -4,585 | -3.90% | ✗ | $926.6K |
| Jul 13, 2021 | Jul 22, 2021 | REPLIGEN CORP | Director | Sell | 20.0 | -1,520 | -1.28% | ✗ | $307.4K |
| Jul 13, 2021 | Jul 15, 2021 | REPLIGEN CORP | Director | Buy | 85.0 | +1,520 | 1.31% | ✗ | $307.4K |
| May 11, 2021 | May 13, 2021 | REPLIGEN CORP | Director | Sell | 40.0 | -285 | -0.25% | ✗ | $50.4K |
| May 4, 2021 | May 6, 2021 | Barinthus Biotherapeutics plc. | Director | Buy | 91.3 | +1,700 | 100.00% | ✗ | $28.9K |
| Jun 18, 2020 | Jun 22, 2020 | REPLIGEN CORP | Director | Sell | 17.5 | -18,705 | -15.66% | ✗ | $2.2M |
| May 20, 2020 | May 21, 2020 | REPLIGEN CORP | Director | Sell | 40.0 | -517 | -0.43% | ✗ | $72.1K |
| May 13, 2020 | May 21, 2020 | REPLIGEN CORP | Director | Sell | 32.5 | -878 | -0.73% | ✗ | $220.4K |
| Apr 20, 2020 | May 21, 2020 | REPLIGEN CORP | Director | Sell | 17.5 | -12,200 | -10.06% | ✗ | $1.3M |
| May 13, 2020 | May 19, 2020 | REPLIGEN CORP | Director | Sell | 32.5 | -878 | -0.73% | ✗ | $220.4K |
| Apr 20, 2020 | Apr 22, 2020 | REPLIGEN CORP | Director | Sell | 17.5 | -12,200 | -10.06% | ✗ | $1.3M |
| Feb 21, 2020 | Feb 24, 2020 | REPLIGEN CORP | Director | Sell | 20.0 | -4,000 | -3.42% | ✗ | $394.8K |
| Jun 17, 2019 | Jun 19, 2019 | REPLIGEN CORP | Director | Sell | 22.5 | -1,295 | -1.09% | ✗ | $100.2K |
| May 11, 2018 | May 15, 2018 | REPLIGEN CORP | Director | Sell | 20.0 | -20,000 | -17.40% | ✗ | $835.9K |
| Mar 21, 2017 | Mar 22, 2017 | REPLIGEN CORP | Director | Sell | 22.5 | -2,521 | -2.63% | ✗ | $86K |
| Jun 27, 2016 | Jun 28, 2016 | REPLIGEN CORP | Director | Sell | 26.3 | -1,982 | -3.43% | ✗ | $46.5K |
| Jun 21, 2013 | Jun 21, 2013 | REPLIGEN CORP | Director | Buy | 82.5 | +1,000 | 3.04% | ✗ | $7.7K |
| Aug 12, 2011 | Aug 15, 2011 | REPLIGEN CORP | Director | Buy | 86.3 | +10,000 | 7.12% | ✗ | $34.9K |
| Jun 14, 2011 | Jun 15, 2011 | REPLIGEN CORP | Director | Buy | 91.3 | +4,500 | 225.00% | ✗ | $16.1K |
| Dec 1, 2008 | Dec 3, 2008 | REPLIGEN CORP | Director | Buy | 82.5 | +2,000 | 4.17% | ✗ | $7K |